retatrutide phase 2 trial type 2 diabetes is investigational and is not FDA approved. In TRANSCEND-T2D-1, investigators randomized 537 adults with inadequately controlled by diet and exercise in a 40-week, double-blind, placebo-controlled 3 retatrutide type 2 diabetes trial
Pay in 4 interest-free payments of $5.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


00967-0/asset/e600c3fc-c7b2-4bc5-adb8-0138decc3ad3/main.assets/gr3_lrg.jpg)
























